Nevertheless, on days 3-17 after inoculation, oral burdens of C. albicans in Tg mice treated with the combination of IL-17 and IL-22 remained significantly greater (p < 0.05) than in untreated control non-Tg mice, showing that this cytokine treatment did not fully restore resistance to oral candidiasis. The gene discussed is IL17A; the disease is oral candidiasis.